mRNA (messenger ribonucleic acid) is made by cells using a process called transcription, where an enzyme copies a DNA gene into a single-stranded RNA molecule. In the lab, mRNA is produced by in vitro transcription (IVT), using a DNA template and purified RNA polymerase. This article explains both natural and laboratory origins, the steps involved, and how synthetic mRNA is used in vaccines and therapies.
Formula
The amount of mRNA produced in an in vitro transcription reaction is estimated by:
mRNA mass (µg) = mass of DNA template (µg) × yield factor (µg mRNA per µg DNA)
mRNA amount (nmol) = [mRNA mass (µg) × 10-6 g/µg] / [mRNA length (nt) × 340 g/mol per nt] × 109 nmol/mol
Where:
- m = mass of DNA template in micrograms (µg)
- l = length of the mRNA transcript in nucleotides (nt)
- y = yield factor, typically 5–20 µg mRNA per µg of DNA template for standard IVT kits (default 10)
- 340 g/mol = average molecular weight of one ribonucleotide (free acid form)
The first output is the total mRNA mass; the second converts that mass to nanomoles, which is useful for downstream calculations like ligation or transfection. The yield factor is an empirical estimate—actual yields depend on template purity, polymerase efficiency, and reaction conditions.
Worked Example
Using the default values: 1 µg of a 1000-nt DNA template, with a yield factor of 10 µg mRNA per µg DNA.
Step 1: Calculate mRNA mass.
mRNA mass = 1 µg × 10 = 10 µg
Step 2: Convert to nanomoles.
mRNA mass in grams = 10 µg × 10-6 g/µg = 1 × 10-5 g
Moles = (1 × 10-5 g) / (1000 nt × 340 g/mol) = 1 × 10-5 / 340000 = 2.941 × 10-11 mol
Nanomoles = 2.941 × 10-11 mol × 109 nmol/mol = 0.02941 nmol
So the calculator returns 10 µg and 0.029 nmol (rounded to 3 decimals).
Assumptions
- Yield factor is constant across template lengths (in practice, longer templates may have lower yields).
- Average ribonucleotide molecular weight is 340 g/mol (free acid, not sodium salt).
- Template is fully double-stranded DNA, and all copies are transcribed.
- No degradation of mRNA during the reaction.
Natural mRNA: Transcription in Cells
In living organisms, mRNA is synthesized in the nucleus (or cytoplasm in prokaryotes) by the enzyme RNA polymerase. The process begins when the enzyme binds to a promoter region on the DNA. It then unwinds the double helix and reads the template strand in the 3′ to 5′ direction, adding complementary RNA nucleotides in the 5′ to 3′ direction. The resulting pre-mRNA undergoes processing in eukaryotes: a 5′ cap is added, a poly-A tail is appended, and introns are removed by splicing. The mature mRNA then travels to ribosomes, where it directs protein synthesis.
Key points about natural mRNA:
- It is transient—mRNA molecules are degraded after a few minutes to hours, allowing cells to regulate gene expression rapidly.
- One gene can produce multiple mRNA isoforms through alternative splicing.
- In humans, mRNA makes up only about 1–5% of total cellular RNA, yet it carries the instructions for all proteins.
Laboratory mRNA: In Vitro Transcription
For research and therapeutic use, mRNA is made outside cells using in vitro transcription (IVT). This method was developed in the 1980s and relies on bacteriophage RNA polymerases such as T7, T3, or SP6. These enzymes are highly processive and require only a short promoter sequence. The typical IVT reaction includes:
- DNA template – a linearized plasmid or PCR product containing the gene of interest downstream of a T7 promoter.
- RNA polymerase – T7 polymerase is most common.
- Ribonucleotide triphosphates (NTPs) – ATP, CTP, GTP, UTP.
- Reaction buffer – contains magnesium ions and a reducing agent.
- Optional modified nucleotides – such as N1-methylpseudouridine, which reduces innate immune activation.
The reaction is incubated at 37 °C for 1–4 hours, then the DNA template is digested with DNase. The mRNA is purified by precipitation or column chromatography. The final product is capped (either co-transcriptionally or enzymatically) and given a poly-A tail to improve stability and translation efficiency.
Sources of DNA Templates
The DNA template for IVT can come from several sources:
- Plasmids – circular DNA vectors engineered with a T7 promoter and a restriction site for linearization.
- PCR products – amplified from genomic DNA or cDNA, with the promoter added via primers.
- Synthetic DNA – gene fragments ordered from commercial suppliers or synthesized in the lab.
For vaccine production, the template often encodes a viral protein (e.g., spike protein of SARS-CoV-2). The template must be free of endotoxins and RNase contamination to ensure high yield and safety.
Modifications and Purification
Natural mRNA is modified post-transcriptionally, but lab-made mRNA requires deliberate modifications. The most important are:
- 5′ cap – a 7-methylguanosine cap added either during transcription (using cap analogs) or after (using capping enzymes). This protects mRNA from degradation and is required for ribosome binding.
- Poly-A tail – a string of 100–150 adenine nucleotides added to the 3′ end, encoded in the template or added enzymatically.
- Modified nucleosides – replacing uridine with N1-methylpseudouridine reduces activation of Toll-like receptors and increases translation.
Purification typically involves DNase treatment, then lithium chloride precipitation or spin columns. For clinical use, high-performance liquid chromatography (HPLC) is used to remove double-stranded RNA contaminants that trigger immune responses.
Common Problems and Misconceptions
A frequent misconception is that mRNA vaccines alter your DNA. In reality, mRNA never enters the nucleus, and it cannot be reverse-transcribed into the genome under normal conditions. Another issue is RNA degradation—RNases are ubiquitous, so lab work requires RNase-free reagents and surfaces.
Common technical problems in IVT:
- Low yield – often due to suboptimal template concentration or inactive polymerase.
- Premature termination – causes truncated transcripts; solved by using high-quality NTPs and adjusting Mg2+ concentration.
- Double-stranded RNA byproducts – can be reduced by using modified nucleotides and lower temperature.
Always follow your lab method, the safety data sheet (SDS) and your supervisor when handling reagents.
Applications of Synthetic mRNA
Synthetic mRNA is used in a growing number of fields:
- Vaccines – mRNA vaccines for infectious diseases like COVID-19, and experimental vaccines for cancer (encoding tumor antigens).
- Gene therapy – mRNA encoding therapeutic proteins (e.g., for cystic fibrosis or enzyme replacement).
- Cell reprogramming – transfecting cells with mRNA for transcription factors to generate induced pluripotent stem cells.
- Research – studying translation, RNA localization, and protein function.
Compared to DNA-based therapies, mRNA does not integrate into the genome, and its expression is transient, which can be an advantage for safety. However, mRNA is fragile and requires lipid nanoparticle delivery to enter cells.
Frequently Asked Questions
Can mRNA be made from protein directly? No. mRNA is always synthesized from a DNA template. Proteins cannot serve as templates for RNA synthesis under normal biological or lab conditions.
Does mRNA come from the nucleus? In eukaryotic cells, mRNA is transcribed in the nucleus and then exported to the cytoplasm. In bacteria, transcription and translation occur simultaneously in the cytoplasm.
How long does mRNA last in a cell? Typically a few hours to a few days, depending on the mRNA sequence and cellular conditions. The poly-A tail and cap help protect it from exonucleases.
Why is mRNA used in vaccines instead of DNA? mRNA does not enter the nucleus, so there is no risk of genomic integration. It also allows rapid production and does not require a viral vector. The main drawbacks are stability and delivery.
What is the difference between mRNA and tRNA? mRNA carries the genetic instructions for a protein, while tRNA (transfer RNA) carries amino acids to the ribosome during translation. Both are RNA, but they have different structures and functions.
Can I make mRNA at home? In principle, IVT requires specialized enzymes and reagents (T7 polymerase, NTPs, buffers) that are not typically available outside a lab. It is not a practical or safe home experiment.
Related
Formula used
in m | Mass of DNA template | µg | 1 | 0 in l | Length of template (nt) | nt | 1000 | 10 in y | Yield of mRNA per µg DNA (µg) | µg/µg | 10 | 0 out mrna | mRNA produced | µg | m * y | 2 out nmol | mRNA amount | nmol | (m * y * 1e-6) / (l * 340) * 1e9 | 3
Each line is one input (in, sel, list) or one result (out: label, unit, formula, decimals). How the calculators work
Method: the standard formula for this calculation with the constants and conversion factors written on the page, rounded as each result states. See method and constants, the disclaimer or report an error.
More in this section
- Within 10 Percent Calculator – How to Use It5.00 %
- Percent Equation: Formula & How to Use It
- W/W Percentage Calculator: Formula & Examples2.92 %
- Percent of a Number Calculator: Find It Instantly20.00 %
- UWW GPA Calculator: How to Compute Your GPA
- PPM to w/w Calculator: Convert Easily5.0000 %